Applied Therapeutics Inc Cash Flow-to-Debt Ratio
Applied Therapeutics Inc cash flow-to-debt ratio. Applied Therapeutics Inc (APLT) has a Cash Flow-to-Debt Ratio of -0.53x as of September 2025, meaning its operating cash flow of $-18.40 Million could theoretically repay -1% of its total liabilities ($34.94 Million) in one year. Check Applied Therapeutics Inc (APLT) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Applied Therapeutics Inc (2017–2024)
Cash flow-to-debt ratio of Applied Therapeutics Inc from 2017 to 2024. Historical debt coverage capacity for Applied Therapeutics Inc across 8 annual periods. Also explore APLT net asset momentum to track the company's year-over-year net asset growth rate.
Applied Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2017–2024)
Applied Therapeutics Inc cash flow-to-debt ratio by year from 2017 to 2024. Year-by-year debt coverage analysis for Applied Therapeutics Inc. For the full cash flow conversion analysis, see APLT cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.84x | $-84.31 Million | $29.68 Million | ▼ -270.5% |
| 2023 | -0.77x | $-55.17 Million | $71.98 Million | ▲ +66.3% |
| 2022 | -2.28x | $-78.09 Million | $34.30 Million | ▲ +31.4% |
| 2021 | -3.32x | $-90.73 Million | $27.35 Million | ▲ +4.3% |
| 2020 | -3.47x | $-78.21 Million | $22.57 Million | ▼ -50.6% |
| 2019 | -2.30x | $-36.31 Million | $15.78 Million | ▲ +8.9% |
| 2018 | -2.53x | $-11.18 Million | $4.43 Million | ▼ -472.8% |
| 2017 | -0.44x | $-3.19 Million | $7.25 Million | — |